NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial.

Chen, Christopher L H; Nguyen, Trong Hung; Marasigan, Simeon; Lee, Chun Fan; Lu, Qingshu; Kandiah, Nagaendran; de Silva, Deidre; Chong, Eddie; Venketasubramanian, Narayanaswamy

Chen, Christopher L H; Nguyen, Trong Hung; Marasigan, Simeon; Lee, Chun Fan; Lu, Qingshu; Kandiah, Nagaendran; de Silva, Deidre; Chong, Eddie; Venketasubramanian, Narayanaswamy.

Afiliação

Chen CLH; Memory and Aging Center Departments of Pharmacology and Psychological Medicine National University of Singapore Singapore.
Nguyen TH; Neurology National Geriatric Hospital Hanoi Vietnam.
Marasigan S; Neurology and Psychiatry University of Santo Tomas Hospital Manila Philippines.
Lee CF; Duke-NUS Centre for Quantitative Medicine Singapore Republic of Singapore.
Lu Q; Singapore Clinical Research Institute Singapore Republic of Singapore.
Kandiah N; Neurology National Neurological Institute Singapore Republic of Singapore.
de Silva D; Neurology Singapore General Hospital Singapore Republic of Singapore.
Chong E; Memory Aging and Cognition Center National University of Singapore Singapore Republic of Singapore.
Venketasubramanian N; Neurology Raffles Neuroscience Centre Singapore Republic of Singapore.

Alzheimers Dement (N Y) ; 7(1): e12161, 2021.

Article em En | MEDLINE | ID: mdl-33816765

Palavras-chave

MLC901; NEUROAID II; clinical trial; executive function; vascular cognitive impairment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google